Cancer vaccines based on mRNA advance, despite US cuts
CHICAGO: Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma and early promise in pancreatic and brain cancers once considered impervious to immune system assault. The apparent breakthroughs in cancer vaccines – deemed one of the fastest-growing segments […]




